肝硬化上消化道出血的微创治疗进展  

Advances in minimally invasive treatment of upper gastrointestinal bleeding in liver cirrhosis

作　　者：徐敏 倪宇 张瑞[1] 王小兵[1] 黄缘[2] XU Min;NI Yu;ZHANG Rui;WANG Xiaobing;HUANG Yuan(Department of Gastroenterology,The First Affiliated Hospital of Harbin Medical University,Harbin 150001,China;Department of Hepatobiliary Medicine,Beijing Tsinghua Changgung Hospital,Tsinghua University,Beijing 102218,China)

机构地区：[1]哈尔滨医科大学附属第一医院消化内科,哈尔滨150001 [2]清华大学附属北京清华长庚医院肝胆内科,北京102218

出　　处：《临床肝胆病杂志》2023年第2期424-431,共8页Journal of Clinical Hepatology

基　　金：黑龙江省博士后科研启动金(LBH-Q20033)。

摘　　要：肝硬化是临床上常见的一种慢性肝病,主要病因包括病毒、酒精、免疫等方面。在肝硬化晚期,患者会出现多种并发症,常见的并发症有上消化道出血、肝性脑病、肝肾综合征以及肝癌等,而上消化道出血则是导致患者死亡的主要原因,所以对于控制及预防肝硬化引起的上消化道出血是降低患者死亡率,延长生存期的关键所在。本综述主要归纳了目前临床上常用的治疗肝硬化上消化道出血的微创手段,通过分析不同治疗方式的适应证及相关的最新进展,为临床医师选择最适合患者实际情况的治疗方案提供了参考,从而提高患者的生存率。Liver cirrhosis is a common chronic liver disease in clinical practice,and the main causes of this disease include virus,alcohol,and immunity.Patients may experience a variety of complications in the late stage of liver cirrhosis,including upper gastrointestinal bleeding,hepatic encephalopathy,hepatorenal syndrome,and liver cancer,among which upper gastrointestinal bleeding is the main cause of death,and therefore,the control and prevention of upper gastrointestinal bleeding caused by liver cirrhosis is the key to reducing mortality rate and prolonging survival time.This article summarizes the commonly used minimally invasive methods for the treatment of upper gastrointestinal bleeding in liver cirrhosis and analyzes the indications for different treatment methods and related advances,so as to provide a reference for clinicians to choose the most suitable treatment regimen for the patient,thereby improving the survival rate of patients.

关 键 词：肝硬化 出血 最小侵入性外科手术 

分 类 号：R575.2[医药卫生—消化系统] R573.2[医药卫生—内科学]